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Even though a thorough clinical examination by a well-
trained neurologist can very often determine precisely the
extent of neurological deficits in a given patient, additional
information is often needed to optimize treatment. Indeed, as
many disease entities are becoming treatable due to im-
provements in pharmacology, surgical techniques and en-
dovascular methods, we as neuroradiologists must position
ourselves more clearly and be able to provide acutely precise
information regarding not just the nature of the lesion but al-
so the potential outcome of any given treatment. The main
areas that come to mind are cerebrovascular diseases, brain
tumors [1] and inflammatory diseases where contrast agents
have greatly improved our insight into the acute pathological
processes that occur in the diseased brain. While we as radi-
ologists are aware of the importance of these techniques, we
have to further explore their implications on patient man-
agement and outcome in order to position ourselves in rela-
tion to other physicians as indispensable partners in the on-
going clinical decision-making process.
Brain imaging was initially revolutionized by the devel-
opment of CT. This was succeeded by MRI. These two
techniques have over the last two decades continued to
evolve and have become invaluable tools for the manage-
ment of patients with neurological diseases. As regards
cerebrovascular diseases, both MRI and CT have undergone
important evolutionary steps over the last few years due to
the widespread availability of perfusion techniques. Simi-
larly, with the emergence of high-powered MR gradients
and MR angiography, it became possible to perform neu-
rovascular imaging from the aortic arch to the circle of
Willis in one session [2]. The advent of diffusion tech-
niques, perfusion imaging and MR spectroscopy also led to
improvements in MRI; these improvements have them-
selves been improved by the continual increase in magnetic
field strength over the years. More recently, with the advent
of faster spiral scanners and with the development of multi-
row detectors, CT technology has caught up and now also
allows neuroangiographic examinations to be performed
that rival conventional digital subtraction angiographic tech-
niques.
Once these technological hardware considerations had
been addressed, it was obvious that contrast media would al-
so be able to contribute to the improvement in image quali-
ty and thus finally to improved patient management. This
we were able to see at a satellite symposium organized by
Bracco during the 2006 Meeting of the ESNR (13–16 Sep-
tember 2006, Geneva, Switzerland). Dr. T. Krings (Aachen,
Germany) demonstrated that the use of improval MR con-
trast agents can provide images of the intra- and extracranial
carotids of very high quality, and this obviously has an im-
portant impact on patient management. Indeed, in less than
a decade, we have seen how MRA has established itself as a
valid alternative to conventional digital subtraction tech-
niques for the work-up of patients with cerebrovascular dis-
eases. CT techniques can also be improved by the use of
high-concentration iodinated contrast media in the carotid
system with an important impact on decisions regarding
therapy, as was explained by Dr. B. Schuknecht (Zurich,
Switzerland). Dr. P. Picozzi (Milan, Italy) demonstrated
how MRI with gadobenate dimeglumine (MultiHance) can
help detect lesions in a way that has major implications for
both neurosurgical planning and follow-up. Parallel to this,
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Dr. P. Schramm (Heidelberg, Germany) demonstrated that
the care of neurosurgical patients can also be improved with
the use of high-concentration iodinated contrast media.
As we can see from the papers in this supplement to Neu-
roradiology, the advent of new contrast media allows us as
neuroradiologists to affect patient management and outcome
safely and reliably. This is an area in which we can con-
tribute together with our partners in the equipment and con-
trast agent industries. Indeed, the development of newer
more powerful contrast agents such as gadobenate dimeglu-
mine for MRI has allowed us to investigate with increased
detail the diseased nervous system and thus to gain further
knowledge leading to improved patient management.
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